MBI Share Price

Open 0.04 Change Price %
High 0.04 1 Day -0.01 -20.00
Low 0.04 1 Week -0.01 -20.00
Close 0.04 1 Month 0.00 0.00
Volume 69000 1 Year -0.03 -42.86
52 Week High 0.08
52 Week Low 0.03
MBI Important Levels
Resistance 2 0.04
Resistance 1 0.04
Pivot 0.04
Support 1 0.04
Support 2 0.04
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
More..
CVE Canada Top Gainers Stocks
ADE 0.02 100.00%
PTR 0.02 100.00%
PTR 0.02 100.00%
PTR 0.02 100.00%
BVQ 0.02 100.00%
GSA 0.02 100.00%
GSA 0.02 100.00%
BGS 0.02 100.00%
BGS 0.02 100.00%
KWF 0.30 100.00%
More..
CVE Canada Top Losers Stocks
CMV 0.01 -50.00%
CMV 0.01 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
IVX 0.06 -45.45%
IVX 0.06 -45.45%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
More..

Med Biogene Inc (CVE: MBI)

MBI Technical Analysis 1.5
As on 23rd Mar 2017 MBI Share Price closed @ 0.04 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.06 & Buy for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
MBI Target for March
1st Target up-side 0.05
2nd Target up-side 0.05
3rd Target up-side 0.05
1st Target down-side 0.03
2nd Target down-side 0.03
3rd Target down-side 0.03
MBI Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.medbiogene.com
MBI Address
MBI
580 Hornby Street
Suite 510
Vancouver, BC V6C 3B6
Canada
Phone: 800-641-3593
Fax: 888-646-2531
MBI Latest News
Med Biogene Inc. Enters Into Settlement Agreement With Helomics Corporation   Yahoo Finance   - 29th Nov 16
Washing clothes releases thousands of microplastic particles into environment   Science Daily   - 03rd Oct 16
Research and Markets: Canada Genetic Testing Market Outlook to 2021 - Acquired ...   Business Wire (press release)   - 11th Dec 15
From activist to CEO, how Iain Weir Jones landed the top job at Med Bio-Gene   Financial Post   - 20th Jun 15
The World Market for Cancer Diagnostics, 5th Edition: Precision and ...   PR Newswire (press release)   - 06th May 14
Med BioGene Announces Regulatory Approval of GeneFx® Lung   Marketwired (press release)   - 24th Mar 14
World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease ...   PR Newswire (press release)   - 11th Feb 13
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition   PR Newswire (press release)   - 06th Aug 12
Sean McDonald   Smart Business Network   - 01st Oct 11
Med Biogene Inc. Stock (CVE:MBI) Advanced, But at What Cost?   HotStocked   - 07th Mar 11
Interactive Technical Analysis Chart Med Biogene Inc ( MBI CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Med Biogene Inc
MBI Business Profile
Med BioGene Inc., a life science company, focuses on managing the license and rights to the genomic-based clinical laboratory diagnostic tests. Its products include the GeneFx Lung, a gene expression-based test for early-stage non-small-cell lung cancer that analyzes the molecular profile of a patient’s tumor to provide information to assist in tailoring treatment for that specific patient. The company has a collaboration agreement with the University Health Network. Med BioGene Inc. was founded in 2002 and is headquartered in Vancouver, Canada.